Researchers designed a new nanoparticle adjuvant that may be more potent than others now in use. Studies in mice showed it significantly improved antibody production following vaccination against HIV, diphtheria and influenza.
from Top Health News -- ScienceDaily https://ift.tt/3xSdP9b
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
India is the largest market by users for both Facebook and its messenger service WhatsApp from Home Page https://ift.tt/3aUtevW via IFTTT...
-
The Finance Industry Development Council (FIDC) has urged the Ministry of Micro, Small & Medium Enterprises (MSME) to address issues fac...
-
Prime Minister Narendra Modi on Saturday said that both India and Bangladesh want to see peace, stability, and love instead of instability, ...
No comments:
Post a Comment